New York, Sept. 20, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the “Animal Antibiotics and Antimicrobials Global Market Report 2022” – https://www.reportlinker.com/p06317624/?utm_source=GNW
, Zydus, Indian Immunologicals Pvt. Ltd, Bayer Animal Health, Virbac Animal Health and Phibro Animal Health Corp.
The global animal antibiotics and antimicrobials market is expected to grow from $4.23 billion in 2021 to $4.49 billion in 2022 at a compound annual growth rate (CAGR) of 6.11%. The market is expected to reach $5.26 billion in 2026 at a compound annual growth rate (CAGR) of 4.04%.
The animal antibiotics and antimicrobials market consists of the sale of animal antibiotics and antimicrobials by entities (organizations, individual traders, partnerships) that refer to veterinary drugs that act against bacteria or microorganisms by killing bacteria/micro-organisms or limiting their growth and multiplication. These drugs are used in animals to treat clinical diseases, to prevent or control common pathological events, and to improve animal growth.
The main types of animal antibiotics and antimicrobials include tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. of the bacterial cytoplasmic membrane.
They are also called oral medications used in the treatment of bacterial infections due to aerobic, gram-negative, mycoplasma and other bacteria. They come in different forms including premixes, oral powder, oral solutions, injections and others.
These drugs are used in both pets and food-producing animals.
North America was the largest region in the animal antibiotics and antimicrobials market in 2021. Asia-Pacific is expected to be the fastest growing region during the forecast period.
Regions covered in Animal Antibiotics and Antimicrobials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle- East and Africa.
The Animal Antibiotics and Antimicrobials Market research report is one of a series of new reports that provide statistics on the Animal Antibiotics and Antimicrobials market, including the global industry market size Animal Antimicrobials and Antimicrobials, Regional Share, Competitors with Animal Antimicrobials and Antimicrobials Market Share, Detailed Animals. Antibiotics and Antimicrobials market segments, market trends and opportunities, and any other data you may need to thrive in the Animal Antibiotics and Antimicrobials industry. This Animal Antibiotics and Antimicrobials Market research report provides a comprehensive perspective of everything you need, with an in-depth analysis of current and future industry scenarios.
The growing demand for food products of animal origin is driving the growth of the animal antibiotics and antimicrobials market. Food products of animal origin such as milk, eggs, meat and others are a major source of nutrition and play a prominent role in human diet.
Companies/institutions involved in the production of foods of animal origin focus on developing a healthy or disease-free herd through the use of antibiotics and antimicrobials for animals on a precautionary basis. According to data published in the Packaged Facts report on global meat and poultry trends, global meat and poultry consumption is expected to reach 313 million metric tons in 2023, at an annual growth rate of 1.4% . Hence, the growing demand for animal-derived food products is expected to drive the demand for animal-derived antibiotics and antimicrobials during the forecast period.
Strategic partnership is a key trend gaining popularity in the animal antibiotics and antimicrobials market.
In May 2022, Gnubiotics Sciences, a Swiss-based biotechnology company working to address microbiome-related health issues in humans and animals, entered into a partnership with ADM, an American developer of human nutrition and health solutions , to commercialize novel microbiome solutions for companion animal health and wellness.
In August 2020, Elanco, a US-based pharmaceutical company that manufactures drugs and vaccines for pets and livestock, acquired Bayer’s animal health business unit for $6.89 billion. With this acquisition, Elanco will enhance its research and development pipeline and expand its line of animal health products. Bayer’s Animal Health business unit is a Germany-based pharmaceutical and life sciences company.
The countries covered in the Animal Antibiotics and Antimicrobials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea South, the United Kingdom and the United States.
Read the full report: https://www.reportlinker.com/p06317624/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.